New feature: Biotech "Tweets of the Week"

Please continue reading below for a new feature that we are excited to roll out here at BiotechDueDiligence. Conceived and curated by biotech trader @23aloha this blog series captures the tweets that best capture the biotech / pharma conversation on Twitter. The conversations here include reaction to and analysis of key market events and trends, as well as observations that in some cases go on to influence biotech stock trading. Feel free to offer any comments as we roll out this new effort!

You've got to be on Twitter

— Brad Loncar (@bradloncar) August 27, 2014

Disappearing messages so teens can sext worth $10B. Disappearing tumors so people live, tiny fractions of that. Says so much about society.

— Bruce Booth (@LifeSciVC) August 27, 2014

Was up $50k on srpt and gave $45k back in one morning...you start noticing the leaves on trees after something like that.

— Randy (@lipscrl) August 28, 2014

6pm PR on Labor Day saying failed endpoint & 70% workforce reduction has to be some kind of new low? $exel

— Joe (@Drchik23) September 1, 2014

@bradloncar approval and FDA in same headline...mmmm

— Juan P. Serrate, DVM (@JPZaragoza1) September 4, 2014

@ColfaxCapital @srqstockpicker Good idea to start slow anytime the immune system is involved.

— avidresearch (@avidresearch) September 5, 2014

Uh oh restricting media and patient access to scientific symposia is not a good thing #ESMO14 http://t.co/Cbbv52h0pU @jangeissler @kgapo

— Sally Church (@MaverickNY) August 25, 2014

Are cancer drug shortages a failure of the market? Pharma? govt? God?

— daviesbj (@daviesbj) September 2, 2014

@MikeNGladstone @mkoeris @scientre @michael_gilman @Alpine_Mitch how many gender-balanced biotechs & funds can you name off top of ur head?

— Ethan O. Perlstein (@eperlste) August 31, 2014